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The absol. configuration of a Ciramadol analogue obtained from (-)-men-
thone is established by 'H-NMR-. simulated NMR-, COSY-90-, and NOE-
measurements. The final compound 2-(a-1 -pyrrolidino)benzy 1-4-isoprop-
yl-1 -methyl-cyclohexan-3-one (4b), e.g.. has l/?.2S,4S.l IS-configuration 
due to stereoselective Michael-type addition of pyrrolidine to the pertinent 
benzylidene intermediate 3. 
Arninocvclanole, 2. Mitt.: Stereochemische Untersuchungen an einem 
neuen Analogon des Ciramadols durch NMR-Spektroskopie 
Die absol. Konfiguration einer Ciramadol-analogen Verbindung aus (-)-
Menthon wurde durch 'H-NMR-. simulierte NMR-. COSY-90- und NOE-
Untersuchungen geklärt. Danach hat die als Beispiel untersuchte Verbin-
dung 2-(a-1 -Pyrrolidino)benzyl-4-isopropyl-1 -methyl-cyclohexan-3-on 
(4b) l#,2S.4S.l IS-Konfiguration, die durch eine stereoselektive Michael-
analoge Addition des Pyrrolidins an die entspr. Benzyliden-Verbindung 3 
entsteht. 
Ciramadol, Tilidin, and Tramadol are aminocyclanoles of clinical impor-
tance as opiat analgesics (Scheme 1 ) V 8 ) . - The mixture of E and Z isomers 
of l/?,4S-2-ben2yüdene-4-isopropyl-l-methyl-cyclohexan-3-one (2 + 3) 
has been prepared by Claisen-Schmidt-type condensation of (-)-menthone 
with benzaldehyde1 .^ The quantitative ratio of these isomers was deter-
mined by gc with ms-detection to be £ 68% and Z 31%l,2). If one of these 
components is dissolved in Et 20 containing a few drops of cone. HCl 
isomerisation to the EfZ mixture of this composition occurs. Only the E 
isomer of this mixture reacts with various cyclic amines to yield amino-
cyclanone type compounds (Scheme 2). These compounds show higher 
opiat analgesic activity than the aminocyclanol compound Tramadol and 
Morphine and can be reduced to the pertinent aminocyclanols 
rac-Tramadol 
Schema 1: Ciramadol, Tilidin, and Tramadol 
In this study we have elucidated the absol. configuration 
of 2-(a-l-pyrrolidino)benzyl-4-isopropyM-methyl-cyclo-
hexan-3-one (4b) as an example by 'H-NMR techniques. 
2-a-(aminobenzyl)menthones 3 have four asymmetric 
C-atoms. As a result, there should be eight pairs of enan-
tiomers. The starting compound (-)-menthone of known 
absol. configuration has two chiral centers (IRAS), [a] D = 
-24°. Therefore, the absol. configurations at C-2 and C - l l 
have to be established. The diastereoselectivity for the 
amine addition at C - l l of the £-(-)-2-benzylidene-men-
thone (3) is quite high, because tic analyses of the crude 
product and its 'H-NMR spectrum show only one isomer. 
In the ! H - N M R spectrum of 4b the doublet at 4.1 ppm 
(J = 11.5 Hz) results from 11-H coupled with 2-H. The dd 
at 3.5 ppm arises from 2-H coupled with 1-H and 11-H 
(J2-i i = 115 Hz; J 2 . i = 4.7 Hz). The region 3.0-4.1 ppm has 
been used for N M R simulation. Several sets of J values 
were used to obtain the simulated N M R spectra. Long-
range couplings were neglected. The spectrum with )2-\\ = 
11.5, J].,, = 0, Ji_ 2 = 4.8 Hz fits the actual N M R spectrum, 
whilst the combination J 2 . j i = 4.8, J M j = 0.0, J,_2 = 11.5 Hz 
does not. 
These results indicate that the methyl group on C - l is 
axial and 1-H is oriented equatorially. 2-H stands in axial 
position and the aminobenzyl group at C-2 equatorially. 
The angle between 2-H and 11-H is near to 180°. A specu-
lative rationalization of the formation of the ß-amino 
ketones 4 is shown in Scheme 2. 
COSY-90 and NOE measurements have been performed 
under the assumption that the absol. configuration at C - l 
and C-4 remain R and S, respectively. The doublet of 2-H 
coupling with 1-H with J = 4.7 Hz indicates an angle of 
about 45°. NOE experiments confirm an axial position of 
2-H, because saturating the signal of 2-H induces a strong 
NOE for 1-H (Tab. 1) (and only a weak NOE on 11-H). In 
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Schema 2: Speculative reaction mechanism 
N(cyti. amine) 
the difference spectrum, the relation resulting from integra-
tion of the signals of i - H and 11-H is 6:1 {equatorial posi-
tion of 2-H should afford a relation being nearly the same 
for both protons, because nearly identical distances for 
1-H/2-H and 2-H/l 1-H (ca. 3 Ä) are shown by the pertinent 
Dreiding model). 2-H and 11-H are arranged trans to each 
other. If there were a s-cis arrangement the NOE-effects 
should be of equal intensity or even opposite. Irradiation 
onto 1-H causes a five times stronger NOE-effect at 2-H 
than at 11-H. If 1-H were arranged axially the NOE-effect 
at 11-H should be larger than that at 2-H as it can be seen 
from Dreiding models. 5-configuration at C - l l is highly 
probable, because there is an NOE of 1-H effecting the 
T- and 5'-pyrrolidine protons (further non-relevant NOE's 
are not cited) (Scheme 3). 
Morever, saturating the resonances of 2-H caused inten-
sive NOE amplification of the ortho-H's of the phenyl ring 
Schema 3: Main NOE effects 
and of the 2 , -H/5'-H , s of the pyrrolidine increment. These 
NOE measurements demonstrate a trans position of 2-H 
and 11-H. This is corroborated by a 3 J value of 11.5 Hz for 
the doublet of 11-H. The connectivities of 2-H and 11-H are 
established by a COSY spectrum. COSY-90 and C O S Y -
long-range experiments confirm the structure shown in 
Scheme 3. 
Saturation of C - 1 - C H 3 resonances leads to a strong 
enhancement of the signals of 1-H and 11-H, whilst there is 
no NOE for 2-H. If 2-H were arranged equatorially, die dis-
tance between 11-H and the C H 3 group should be > 3.5 Ä, 
so excluding an NOE. Moreover, in this case there should 
be an N O E between the methyl protons and 2-H (distance 
about 2 A). 
From these experiments we conclude that the absol. con-
figuration at C-2 is S and that there is a favoured conforma-
tion having 2-H and 11-H trans to each other. 
Experimental Part 
2-(a-Aminobenzyl)-menthones 4 were prepared as reported1 -2).- } H -
NMR spectra for simulation - see above - were recorded at 20°C on a Bro-
ker AC-80 MHz FT-NMR in CDC13, TMS as internal standard, using the 
PANIC program.- Chemical shifts in 8 (ppm). 
'H-NMR, 400 MHz, CDC13 (TMS) 23°C of 4b (Bruker ARX 400): 5 = 
0.65 (d, J = 6.7 Hz, 3H. 9-CH3 or 10-CH3), 0.77 (d, J = 6.8 Hz, 3H, 10-
C H 3 or 9-CH3), 0.84 (d, J = 7.1 Hz. 3H, 7-CH3), 1.48-1.62 (m, 5H, 1 ment-
hone-H, 3'-CH 2 , 4 , -CH : ) . 1.75-1.80 (m. 1H, menthone-H), 1.85-1.93 
(sept, J « 6.7 Hz, 1H, 8-H), 1.95-2.07 (m, 3H, menthone-H), 2.27-2.44 (m, 
4H, 2'-CH 2 , 5*-CH2), 2.79 (or.. 1H, I-H), 3.38 (dd, J = 4.7 Hz, J = 11.5 
Hz, 1H, 2-H), 4.1 l(d. J = 11.5 Hz, 1H, 11-H). 7.09-7.29 (m. 5 arom. H). 
Tab. 1: NOE effect of 2-(a-pyrrolidino)benzyl-4-isopropyl-l-methylcyclohexan-3-one (4b) 
NOE of 
1-H to 11-H (w), 2-H (s), 2'-H / 5'-H (s),7-CH3 (s) and menthone ring 
2-H to 11-H (w), 1-H (s), 2'-H / 5'-H'(s). o-phenyl-Hs (s)t 7-CH 3 (s) 
11-H to 1-H (w), 2-H(w), 2'-H / 5'-H (s), o-phenyl-H's (s) and 7-CH3 (s) 
7-CH3 to 1-H (s), 11-H (s) and menthone ring (s) 
9- / IÖ-CH3 to 4-H (s) and menthone ring (s) 
4-H to 9-CH3 / IO-CH3 (s) and menthone ring (s) 
w: weak* s: strong 
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COSY-90 and NOE experiments were performed on a Bruker ARX 400. 
The COSY-90 data were recorded with IK and 256 points in the t2 and t, 
dimensions, respectively. NOE spectra were recorded using NOEMUL 
pulse program. The data size was 32 K. 
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